/
4888.T
No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
Stella Pharma Corporation
Stella Pharma Corporation is a pharmaceutical company that handles the complete process of drug development, from research and manufacturing to distribution. A core area of its specialization is in therapeutic agents for boron neutron capture therapy (BNCT). Their product lineup includes SPM-011, a boron-containing drug designed for BNCT, which is utilized in the treatment of head and neck cancer, recurrent malignant glioma, meningioma, malignant melanoma, and angiosarcoma. Founded in 2007, Stella Pharma Corporation maintains its headquarters in Osaka, Japan.
www.stella-pharma.co.jp- Employees
- 47
- IPO / List date
- Apr 22, 2021
- HQ
- JP
Held by traders on TradeandTell
No one on the platform currently holds 4888.T.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in 4888.T as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded 4888.T yet.